- Report
- July 2023
- 119 Pages
Global
From €4324EUR$4,500USD£3,697GBP
- Report
- January 2024
- 146 Pages
Global
From €4084EUR$4,250USD£3,491GBP
- Report
- November 2023
- 140 Pages
Global
From €4276EUR$4,450USD£3,656GBP
- Report
- December 2023
Global
From €7206EUR$7,500USD£6,161GBP
- Newsletter
- May 2024
Global
€2878EUR$2,995USD£2,460GBP
- Report
- December 2023
- 190 Pages
Global
€4799EUR$4,995USD£4,103GBP
- Report
- October 2023
- 102 Pages
Latin America
From €5717EUR$5,950USD£4,888GBP
- Report
- June 2023
- 79 Pages
North America
From €1441EUR$1,500USD£1,232GBP
- Report
- April 2022
- 400 Pages
Global
€1681EUR$1,750USD£1,438GBP
- Report
- February 2022
- 230 Pages
Global
From €4611EUR$4,799USD£3,942GBP
- Report
- February 2021
- 112 Pages
Global
From €1321EUR$1,375USD£1,130GBP
€2642EUR$2,750USD£2,259GBP
- Report
- May 2019
- 148 Pages
Global
From €1321EUR$1,375USD£1,130GBP
€2642EUR$2,750USD£2,259GBP
- Report
- September 2021
- 77 Pages
United States
From €3363EUR$3,500USD£2,875GBP
- Report
- May 2020
- 482 Pages
Global
From €9128EUR$9,500USD£7,804GBP
- Report
- November 2021
- 156 Pages
Global
From €6678EUR$6,950USD£5,709GBP
- Report
- January 2022
- 200 Pages
Global
From €7206EUR$7,500USD£6,161GBP
- Report
- January 2022
- 60 Pages
Global
From €3795EUR$3,950USD£3,245GBP
- Report
- January 2022
- 60 Pages
Global
From €3795EUR$3,950USD£3,245GBP
- Report
- April 2023
- 120 Pages
Global
From €4564EUR$4,750USD£3,902GBP
- Report
- April 2023
- 120 Pages
Global
From €4564EUR$4,750USD£3,902GBP
The Bone Marrow market is a subset of the biotechnology industry that focuses on the development of treatments and therapies for diseases related to the bone marrow. This includes treatments for blood cancers such as leukemia, lymphoma, and multiple myeloma, as well as treatments for bone marrow failure syndromes. Bone marrow transplants are also used to treat a variety of other conditions, such as sickle cell anemia and thalassemia.
The Bone Marrow market is driven by advances in biotechnology, such as gene therapy, stem cell research, and immunotherapy. These technologies have enabled researchers to develop more effective treatments for bone marrow-related diseases. Additionally, the increasing prevalence of these diseases has created a demand for new treatments and therapies.
Some companies in the Bone Marrow market include Celgene, Gilead Sciences, Novartis, and Kite Pharma. These companies are involved in the development of treatments and therapies for bone marrow-related diseases, as well as the production of bone marrow transplants. Show Less Read more